e-learning
resources
ERJ
2013
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Criteria for clinical stability in hospitalised patients with community-acquired pneumonia
Stefano Aliberti, Anna Maria Zanaboni, Tim Wiemken, Ahmed Nahas, Srinivas Uppatla, Letizia Corinna Morlacchi, Paula Peyrani, Francesco Blasi, Julio Ramirez
Source:
Eur Respir J 2013; 42: 742-749
Journal Issue:
September
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Stefano Aliberti, Anna Maria Zanaboni, Tim Wiemken, Ahmed Nahas, Srinivas Uppatla, Letizia Corinna Morlacchi, Paula Peyrani, Francesco Blasi, Julio Ramirez. Criteria for clinical stability in hospitalised patients with community-acquired pneumonia. Eur Respir J 2013; 42: 742-749
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Biomarkers and clinical stability in community-acquired pneumonia
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009
Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009
Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
Etiology and clinical outcome of community-acquired pneumonias in hospitalized children
Source: Eur Respir J 2007; 30: Suppl. 51, 398s
Year: 2007
Clinical stability and switch therapy in hospitalised patients with community-acquired pneumonia: are we there yet?
Source: Eur Respir J 2013; 41: 5-6
Year: 2013
The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Clinical characteristics of extremely elderly patients with community-acquired and healthcare-associated pneumonia in Japan
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Clinical failure in community-acquired pneumonia
Source: International Congress 2014 – PG16 Low respiratory tract infections: learning from real clinical cases
Year: 2014
Clinical characteristics of the patients with community-acquired Legionella pneumonia in advanced age
Source: Eur Respir J 2005; 26: Suppl. 49, 410s
Year: 2005
Adherence to guidelines and clinical stability in community-acquired pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 241s
Year: 2004
Community-acquired pneumonia (CAP): evaluation of severity criteria for hospitalization
Source: Eur Respir J 2003; 22: Suppl. 45, 335s
Year: 2003
Bacteriological diagnosis in hospitalized community-acquired pneumonia (HCAP): an eighteen-month study
Source: Eur Respir J 2001; 18: Suppl. 33, 541s
Year: 2001
Clinical feature of Japanese patients with healthcare-associated pneumonia
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Differential clinical and etiological features in young and elderly patients hospitalized due to community-acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002
Heliox-therapy of patients with execerbation of COPD and community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 106s
Year: 2006
Timing of previous hospitalizations impacts outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
Management of community-acquired pneumonia in adult outpatients
Source: Eur Respir J 2006; 28: Suppl. 50, 377s
Year: 2006
Seasonal variation in outcome for hospitalised patients with community-acquired pneumonia
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Another view on the prediction of outcomes in patients with community-acquired pneumonia
Source: Eur Respir J 2011; 38: 992-993
Year: 2011
Another view on the prediction of outcomes in patients with community-acquired pneumonia
Source: Eur Respir J 2011; 38: 991-992
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept